Valuation: Viyash Scientific Limited

Market Cap 12TCr 127.08Cr 109.92Cr 102.65Cr 94Cr 177.12Cr 179.93Cr 1.2TCr 472.71Cr 6.06TCr 477.21Cr 466.76Cr 20TCr P/E 2027 *
33.2x
P/E 2028 * 20.8x
Enterprise Value 12TCr 127.08Cr 109.92Cr 102.65Cr 94Cr 177.12Cr 179.93Cr 1.2TCr 472.71Cr 6.06TCr 477.21Cr 466.76Cr 20TCr EV / Sales 2027 *
3.1x
EV / Sales 2028 * 2.73x
Free-Float
32.55%
Yield 2027 *
-
Yield 2028 * -
1 day+1.54%
1 week+9.94%
Current month+9.94%
1 month+2.25%
3 months+26.53%
6 months+37.45%
Current year+33.13%
1 week 252.5
Extreme 252.5
281.15
1 month 248.05
Extreme 248.05
285.2
Current year 178.4
Extreme 178.4
297.9
1 year 167.5
Extreme 167.5
297.9
3 years 86.03
Extreme 86.03
297.9
5 years 61.8
Extreme 61.8
297.9
10 years 42.45
Extreme 42.45
336.4
Manager TitleAgeSince
Chief Executive Officer 62 16/12/2025
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 05/02/2026
Director TitleAgeSince
Chairman 78 -
Director/Board Member 66 25/08/2020
Director/Board Member 57 11/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+9.94%+64.70%+171.11% 127.08Cr
-0.52%+3.21%+89.52%+127.32% 1,05700Cr
+0.88%+1.13%+49.56%+49.69% 62TCr
+0.89%-1.95%+24.23%+64.44% 43TCr
+0.71%+3.87%+49.07%+37.85% 36TCr
+0.64%-0.49%+33.94%+40.01% 30TCr
+0.39%-5.83%+8.92%+7.85% 25TCr
+1.51%+6.69%+42.58%+57.57% 22TCr
+3.92%-0.46%-5.56%-52.32% 21TCr
+1.80%+2.30%+11.56%+66.35% 17TCr
Average +1.18%+1.77%+36.85%+56.99% 36.22TCr
Weighted average by Cap. +0.66%+1.22%+48.73%+64.67%

Financials

2027 *2028 *
Net sales 3.9TCr 41Cr 35Cr 33Cr 30Cr 57Cr 58Cr 388.31Cr 152.41Cr 1.95TCr 153.86Cr 150.49Cr 6.46TCr 4.43TCr 47Cr 40Cr 38Cr 34Cr 65Cr 66Cr 440.95Cr 173.07Cr 2.22TCr 174.72Cr 170.89Cr 7.34TCr
Net income 383.23Cr 4.03Cr 3.48Cr 3.25Cr 2.98Cr 5.61Cr 5.7Cr 38Cr 15Cr 192.09Cr 15Cr 15Cr 635.03Cr 582.23Cr 6.12Cr 5.29Cr 4.94Cr 4.53Cr 8.53Cr 8.66Cr 58Cr 23Cr 291.83Cr 23Cr 22Cr 964.78Cr
Net Debt - -
Logo Viyash Scientific Limited
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Employees
2,900
Date Price Change Volume
07/26/07 ₹277.10 +1.54% 96,153
06/26/06 ₹272.90 -0.24% 58,342
05/26/05 ₹273.55 +2.66% 1,50,611
04/26/04 ₹266.45 +0.99% 1,02,577
03/26/03 ₹263.85 +4.68% 1,49,920
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
277.10INR
Average target price
312.67INR
Spread / Average Target
+12.84%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIYASH Stock